Bicocca Open Archive

Logo unimib boa
GEETA, GEETA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.147
EU - Europa 1.201
AS - Asia 1.040
SA - Sud America 152
AF - Africa 29
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 4
Totale 4.578
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.104
SG - Singapore 374
CN - Cina 301
IT - Italia 297
DE - Germania 250
RU - Federazione Russa 161
HK - Hong Kong 139
BR - Brasile 127
SE - Svezia 111
IE - Irlanda 104
VN - Vietnam 68
GB - Regno Unito 66
PL - Polonia 50
FR - Francia 44
IN - India 39
CA - Canada 31
ID - Indonesia 31
UA - Ucraina 27
FI - Finlandia 19
BE - Belgio 14
JP - Giappone 14
NL - Olanda 14
TR - Turchia 14
ZA - Sudafrica 12
BD - Bangladesh 11
DK - Danimarca 11
KR - Corea 10
AR - Argentina 9
MX - Messico 9
AT - Austria 8
IR - Iran 8
ES - Italia 6
PE - Perù 6
GR - Grecia 5
AE - Emirati Arabi Uniti 4
EU - Europa 4
SA - Arabia Saudita 4
TN - Tunisia 4
TW - Taiwan 4
VE - Venezuela 4
AU - Australia 3
IL - Israele 3
IQ - Iraq 3
JO - Giordania 3
MA - Marocco 3
NO - Norvegia 3
UZ - Uzbekistan 3
CH - Svizzera 2
CO - Colombia 2
DZ - Algeria 2
EC - Ecuador 2
KE - Kenya 2
KG - Kirghizistan 2
LT - Lituania 2
MY - Malesia 2
RO - Romania 2
SO - Somalia 2
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CL - Cile 1
DO - Repubblica Dominicana 1
EG - Egitto 1
HN - Honduras 1
HR - Croazia 1
IS - Islanda 1
MK - Macedonia 1
NG - Nigeria 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PY - Paraguay 1
SC - Seychelles 1
SN - Senegal 1
TO - Tonga 1
Totale 4.578
Salva come PNG Salva come JPEG
Città #
Ann Arbor 673
Singapore 206
Ashburn 189
Frankfurt am Main 189
Hong Kong 134
Milan 125
Chandler 124
Wilmington 118
Fairfield 107
Dublin 103
New York 60
Woodbridge 56
Beijing 48
Los Angeles 48
Seattle 44
Dearborn 42
Dallas 41
Houston 39
Lodz 36
Cambridge 33
Princeton 30
Jakarta 28
Santa Clara 28
Ho Chi Minh City 27
Shanghai 24
Munich 20
Buffalo 19
Hefei 17
Nanjing 16
Moscow 15
The Dalles 15
Brussels 14
Lawrence 14
Chicago 13
Fremont 13
Hanoi 12
Johannesburg 11
Altamura 10
Changsha 10
Hangzhou 10
Ottawa 10
Phoenix 10
São Paulo 10
Warsaw 10
Council Bluffs 9
Jacksonville 9
London 9
Seoul 9
Nuremberg 8
Toronto 8
Turku 8
Andover 7
Guangzhou 7
Helsinki 7
Jinan 7
Norwalk 7
San Diego 7
Stockholm 7
Boston 6
Columbus 6
Edmonton 6
Kent 6
Monza 6
Poplar 6
Shenyang 6
Tianjin 6
Tokyo 6
Brooklyn 5
Campinas 5
Corsico 5
Hebei 5
Kiev 5
Nanchang 5
Redmond 5
Romola 5
Amsterdam 4
Aylesbury 4
Bergamo 4
Cagliari 4
Chennai 4
Como 4
Concord 4
Denver 4
Desio 4
Dong Ket 4
Düsseldorf 4
Erzurum 4
Haiphong 4
Lappeenranta 4
Lissone 4
Manchester 4
Meaux 4
Montreal 4
Mumbai 4
Orem 4
Rio de Janeiro 4
San Francisco 4
Vienna 4
Zhengzhou 4
Amman 3
Totale 3.103
Salva come PNG Salva come JPEG
Nome #
Lorlatinib treatment elicits multiple on- and off-target mechanisms of resistance in ALK-driven cancer 436
Wiskott–Aldrich syndrome protein (WASP) is a tumor suppressor in T cell lymphoma 397
Long-term efficacy and safety of crizotinib in relapsed ALK positive lymphoma patients: clinical and biological correlates 396
A Compound L1196M/G1202R ALK Mutation in a Patient with ALK-Positive Lung Cancer with Acquired Resistance to Brigatinib Also Confers Primary Resistance to Lorlatinib 344
In vitro and in vivo characterization of resistance to lorlatinib treatment in ALK mutated cancers 338
Concomitant BCORL1 and BRAF Mutations in Vemurafenib-Resistant Melanoma Cells 297
Phase two study of crizotinib in patients with anaplastic lymphoma kinase (ALK) positive anaplastic large cell lymphoma relapsed/refractory to chemotherapy 297
Abstract 902: In vitro andin vivocharacterization of resistance to lorlatinib treatment in ALK mutated cancers 279
Tumor Resistance against ALK Targeted Therapy-Where It Comes From and Where It Goes 236
We shall overcome (drug resistance) some day 233
Phase ii study with crizotinib in patients with anaplastic lymphoma kinase (alk)-positive lymphoma relapsed/refractory to chemotherapy 229
STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma 220
New pan-ALK inhibitor-resistant EML4::ALK mutations detected by liquid biopsy in lung cancer patients 213
Synergistic drug combinations prevent resistance in ALK+ anaplastic large cell lymphoma 210
Recurrent somatic mutations of FAT family cadherins induce an aggressive phenotype and poor prognosis in anaplastic large cell lymphoma 187
IL10RA modulates crizotinib sensitivity in NPM1-ALK+ anaplastic large cell lymphoma 181
New advances in liquid biopsy technologies for anaplastic lymphoma kinase (Alk)—positive cancer 173
Abstract 987: Novel ALK mutations in EML4::ALK+ NSCLC resistant to TKIs identified by liquid biopsy 127
Totale 4.793
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.702
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.702
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021503 0 0 0 0 0 99 72 92 59 58 59 64
2021/2022314 42 56 40 25 16 16 20 9 13 15 26 36
2022/2023567 53 150 72 51 45 76 7 35 22 39 9 8
2023/2024361 7 10 20 17 32 93 58 24 37 14 10 39
2024/2025988 50 74 33 50 116 52 82 33 126 157 82 133
2025/20261.044 227 104 217 228 239 29 0 0 0 0 0 0
Totale 4.793